3D Bio-Tissues Bio-equivalent tissues
3D Bio-Tissues (3DBT) is at the forefront of producing bio-equivalent tissues for clinical and cellular agriculture markets. 3DBT is focused on the development of the next generation of cutting-edge biotech solutions aimed at radically transforming the delivery of sustainable solutions. Product Highlight: CityMix
3Helix Collagen Hybridizing Peptides (CHP)
3Helix is based in Salt Lake City, Utah. It was founded by Drs. Yang Li and Michael Yu based on the technology that they invented at the Johns Hopkins University. Damage to collagen, the major component of nearly every human tissue, is a strong indication of connective tissue injury, as well as a variety of diseases. However, targeting damaged collagen is difficult with conventional technologies. 3Helix has developed a series of proprietary collagen hybridizing peptides (CHP) that directly target the damaged collagen molecule. ...
4basebio Genomics and Molecular Biology
The Spanish company 4basebio focuses on the development and distribution of new molecular biological technologies, used for example in DNA amplification and sequencing. The portfolio includes the former Sygnis and CBS products. Product Range: - TruePrime® DNA Amplification - CovCheck(TM) Genome Coverage WGA QC Kits - MagniPhi® and QualiPhi® DNA Polymerases - DNA Ladders - SunScript® Reverse Transcriptase